Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists' Survey based data.
career development
gender inequalities
gender-related differences
gynecologic oncology surgeons
leadership
salary
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
07
2022
accepted:
15
11
2022
entrez:
5
1
2023
pubmed:
6
1
2023
medline:
6
1
2023
Statut:
epublish
Résumé
Gender-related differences in career development are well known issues in various professions. An international survey on gender-related differences was performed among young gynecologic oncology surgeons in Europe to identify potential gender inequalities in career development. A survey on demographics, clinical and academic working environment, family/parenting, career development, salary and leadership was sent to all members of the European Network of Young Gynecologic Oncologists (ENYGO), which is a network within the European Society of Gynecologic Oncology (ESGO). Gynecologic oncology surgeons and obstetricians/gynecologists who actively work in this field in Europe were included in the study. Responses were analyzed from 192 gynecologic oncology surgeons of whom 65.1% (125/192) were female (median age 37, IQR: 34 - 42) and 34.9% (67/192) were male (median age 38, IQR: 36 - 41). Male reported to perform a median of 15 and female a median of 10 operations per month This first comprehensive survey on gender-differences in gynecologic oncology in Europe revealed that there are gender gaps concerning several aspects during the critical time of career development in the young generation of gynecologic oncology surgeons. These gender gaps are particularly reflected by a lower rate of female leadership positions. ENYGO and ESGO are dedicated to work on solution to overcome the identified obstacles and to support closing gender gaps.
Identifiants
pubmed: 36601477
doi: 10.3389/fonc.2022.1005130
pmc: PMC9807173
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1005130Informations de copyright
Copyright © 2022 Nikolova, Bossart, Kacperczyk-Bartnik, Razumova, Strojna, Bizzarri, Pletnev, Gómez-Hidalgo, Theofanakis, Lanner, Selcuk, Shushkevich, Anca, Nikolova, Concin and Zalewski.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Gynecol Oncol Rep. 2019 Jul 26;29:83-84
pubmed: 31417953
Gynecol Oncol. 2020 Jun;157(3):759-764
pubmed: 32276792
Am J Obstet Gynecol. 2020 Nov;223(5):665-673
pubmed: 32585225
Ann Intern Med. 2014 Mar 4;160(5):344-53
pubmed: 24737273
Obstet Gynecol. 2015 Feb;125(2):471-476
pubmed: 25568998
JAMA Netw Open. 2020 Mar 2;3(3):e200708
pubmed: 32159809
Acad Med. 2016 Aug;91(8):1050-2
pubmed: 27332868
ESMO Open. 2021 Apr;6(2):100048
pubmed: 33556897
J Womens Health (Larchmt). 2015 Mar;24(3):190-9
pubmed: 25658907
Acad Med. 2016 Aug;91(8):1119-27
pubmed: 27254008
Ann Intern Med. 2004 Aug 3;141(3):205-12
pubmed: 15289217
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100178
pubmed: 33345906
BMJ. 2017 Oct 10;359:j4366
pubmed: 29018008
J Minim Invasive Gynecol. 2022 Aug;29(8):952-960
pubmed: 35378266
Acad Med. 2016 Aug;91(8):1068-73
pubmed: 27276007
Postgrad Med J. 2016 Oct;92(1092):571-5
pubmed: 27528703
Am J Obstet Gynecol. 2018 Oct;219(4):364.e1-364.e4
pubmed: 30017680
Womens Health Rep (New Rochelle). 2021 Apr 08;2(1):78-84
pubmed: 33937904
ESMO Open. 2018 Sep 21;3(6):e000422
pubmed: 30273420
Int J Gynecol Cancer. 2022 May 3;32(5):583-589
pubmed: 35304410
BMC Health Serv Res. 2010 Feb 18;10:40
pubmed: 20167075
JAMA. 2012 Jun 13;307(22):2410-7
pubmed: 22692173
Acad Med. 2016 Aug;91(8):1057-64
pubmed: 27191836
Obstet Gynecol. 2015 Dec;126(6):1279-1284
pubmed: 26551177
J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1088-1094
pubmed: 30389582